Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus

Abstract

Zanamivir, a neuraminidase inhibitor, has shown promise as a drug to control influenza. During prolonged treatment with zanamivir, a mutant virus was